Table 3 Adverse events during neoadjuvant therapy
Adverse events | ESCC patients (N = 16) |
|---|---|
Hematologic, no. (%) | |
WBC decreased | 6 (37.5) |
Neutrophil decreased | 5 (31.3) |
Anemia | 2 (12.5) |
Thrombocytopenia | 2 (12.5) |
Non-hematologic, no. (%) | |
RCCEP | 6 (37.5) |
Nausea or vomiting | 4 (25.0) |
Decreased appetite | 3 (18.8) |
Baldness | 3 (18.8) |
Diarrhea | 2 (12.5) |
Constipation | 2 (12.5) |
Fatigue | 1 (6.3) |
Rash | 1 (6.3) |